Radiation-Induced Skin Fibrosis Pathogenesis, Current Treatment Options, and Emerging Therapeutics

被引:112
作者
Borrelli, Mimi R. [1 ]
Shen, Abra H. [1 ]
Lee, Gordon K. [2 ]
Momeni, Arash [2 ]
Longaker, Michael T. [1 ,3 ]
Wan, Derrick C. [2 ]
机构
[1] Stanford Univ, Dept Surg, Sch Med, Hagey Lab Pediat Regenerat Med,Div Plast Surg, Stanford, CA USA
[2] Stanford Univ, Div Plast & Reconstruct Surg, Med Ctr, Palo Alto, CA USA
[3] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA
基金
美国国家卫生研究院;
关键词
fat grafting; fibrosis; radiation-induced fibrosis; radiodermatitis; CELL-ASSISTED LIPOTRANSFER; GROWTH-FACTOR-BETA; BREAST-CANCER; AUTOLOGOUS FAT; DOUBLE-BLIND; FOLLOW-UP; RANDOMIZED-TRIAL; SUPPORTIVE USE; RADIOTHERAPY; THERAPY;
D O I
10.1097/SAP.0000000000002098
中图分类号
R61 [外科手术学];
学科分类号
摘要
Radiotherapy (RT) has become an indispensable part of oncologic treatment protocols for a range of malignancies. However, a serious adverse effect of RT is radiodermatitis; almost 95% of patients develop moderate to severe skin reactions following radiation treatment. In the acute setting, these can be erythema, desquamation, ulceration, and pain. Chronically, soft tissue atrophy, alopecia, and stiffness can be noted. Radiodermatitis can delay oncologic treatment protocols and significantly impair quality of life. There is currently a paucity of effective treatment options and prevention strategies for radiodermatitis. Importantly, recent preclinical and clinical studies have suggested that fat grafting may be of therapeutic benefit, reversing detrimental changes to soft tissue following RT. This review outlines the damaging effects of RT on the skin and soft tissue as well as discusses available treatment options for radiodermatitis. Emerging strategies to mitigate detrimental, chronic radiation-induced changes are also presented.
引用
收藏
页码:S59 / S64
页数:6
相关论文
共 111 条
  • [1] The Use of Antioxidants in Radiotherapy-Induced Skin Toxicity
    Amber, Kyle T.
    Shiman, Michael I.
    Badiavas, Evangelos V.
    [J]. INTEGRATIVE CANCER THERAPIES, 2014, 13 (01) : 38 - 45
  • [2] [Anonymous], 2018, J AM ACAD DERMATOL
  • [3] [Anonymous], 2007, CANC FACTS FIG 2015
  • [4] PATHOPHYSIOLOGY OF IRRADIATED SKIN AND BREAST
    ARCHAMBEAU, JO
    PEZNER, R
    WASSERMAN, T
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05): : 1171 - 1185
  • [5] Stress signaling frorn irradiated to non-irradiated cells
    Azzam, EI
    de Toledo, SM
    Little, JB
    [J]. CURRENT CANCER DRUG TARGETS, 2004, 4 (01) : 53 - 64
  • [6] Baskar Rajamanickam, 2014, Front Mol Biosci, V1, P24, DOI 10.3389/fmolb.2014.00024
  • [7] Cancer and Radiation Therapy: Current Advances and Future Directions
    Baskar, Rajamanickam
    Lee, Kuo Ann
    Yeo, Richard
    Yeoh, Kheng-Wei
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (03): : 193 - 199
  • [8] GENOMIC INSTABILITY IN CANCER Strategies to improve radiotherapy with targeted drugs
    Begg, Adrian C.
    Stewart, Fiona A.
    Vens, Conchita
    [J]. NATURE REVIEWS CANCER, 2011, 11 (04) : 239 - 253
  • [9] LATENT-TIME ESTIMATION FOR LATE CUTANEOUS AND SUBCUTANEOUS RADIATION REACTIONS IN A SINGLE-FOLLOW-UP CLINICAL-STUDY
    BENTZEN, SM
    THAMES, HD
    OVERGAARD, M
    [J]. RADIOTHERAPY AND ONCOLOGY, 1989, 15 (03) : 267 - 274
  • [10] Berkey FJ, 2010, AM FAM PHYSICIAN, V82, P381